Robert Boigegrain

897 total citations
18 papers, 761 citations indexed

About

Robert Boigegrain is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Robert Boigegrain has authored 18 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in Robert Boigegrain's work include Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (9 papers) and Chemical Synthesis and Analysis (3 papers). Robert Boigegrain is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (9 papers) and Chemical Synthesis and Analysis (3 papers). Robert Boigegrain collaborates with scholars based in France, Italy and Belgium. Robert Boigegrain's co-authors include Martine Poncelet, Michel Héaulme, Christiane Gueudet, D. Gully, Roger Leyris, Aline Brouard, Philippe Soubrié, Danielle Gully, Patrick Kitabgi and André Bachy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

In The Last Decade

Robert Boigegrain

17 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Boigegrain France 9 605 560 133 93 58 18 761
Christine Batzl‐Hartmann Germany 7 748 1.2× 527 0.9× 163 1.2× 125 1.3× 39 0.7× 8 1.1k
H. YAJIMA Japan 14 329 0.5× 311 0.6× 43 0.3× 92 1.0× 64 1.1× 36 619
D. Gully France 12 727 1.2× 597 1.1× 171 1.3× 83 0.9× 6 0.1× 17 818
Kelly P. Longo United States 11 1.0k 1.7× 947 1.7× 31 0.2× 366 3.9× 194 3.3× 14 1.4k
J.B. Bøler United States 6 260 0.4× 209 0.4× 134 1.0× 57 0.6× 23 0.4× 8 662
Fredric J. Vinick United States 10 650 1.1× 687 1.2× 20 0.2× 234 2.5× 191 3.3× 25 1.0k
Bernard Labeeuw France 5 282 0.5× 238 0.4× 53 0.4× 36 0.4× 22 0.4× 6 348
J P Moreau United States 10 427 0.7× 431 0.8× 16 0.1× 31 0.3× 35 0.6× 12 731
Larry S. Birkemo United States 8 319 0.5× 297 0.5× 71 0.5× 35 0.4× 50 0.9× 10 459
D. Roemer Japan 8 461 0.8× 436 0.8× 20 0.2× 189 2.0× 52 0.9× 14 673

Countries citing papers authored by Robert Boigegrain

Since Specialization
Citations

This map shows the geographic impact of Robert Boigegrain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Boigegrain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Boigegrain more than expected).

Fields of papers citing papers by Robert Boigegrain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Boigegrain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Boigegrain. The network helps show where Robert Boigegrain may publish in the future.

Co-authorship network of co-authors of Robert Boigegrain

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Boigegrain. A scholar is included among the top collaborators of Robert Boigegrain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Boigegrain. Robert Boigegrain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Alonso, Richard, M. Arnone, Robert Boigegrain, et al.. (1999). SR146131: A New Potent, Orally Active, and Selective Nonpeptide Cholecystokinin Subtype 1 Receptor Agonist. II: In Vivo Pharmacological Characterization. Journal of Pharmacology and Experimental Therapeutics. 289(2). 752–761. 25 indexed citations
2.
Quéré, Luc, et al.. (1998). X-ray structural characterization of SR 142948, a novel potent synthetic neurotensin receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 8(6). 653–658. 8 indexed citations
3.
Gully, Danielle, Bernard Labeeuw, Robert Boigegrain, et al.. (1997). Biochemical and Pharmacological Activities of SR 142948A, a New Potent Neurotensin Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 280(2). 802–812. 181 indexed citations
4.
Quéré, Luc, et al.. (1996). Structural requirements of non-peptide neurotensin receptor antagonists. Journal of the Chemical Society Perkin Transactions 2. 2639–2646. 11 indexed citations
5.
Maffrand, Jean‐Pierre, et al.. (1995). NEW POTENT AND SELECTIVE NON-PEPTIDE ANTAGONISTS OF NEUROTENSIN RECEPTORS. European Journal of Medicinal Chemistry. 30. 551s–573s. 2 indexed citations
6.
Boigegrain, Robert, et al.. (1995). SR 46559A, AN ATYPICAL MUSCARINIC COMPOUND WITH NO CHOLINERGIC SYNDROME : CHEMICAL APPROACH AND PHARMACOLOGICAL PROFILE. European Journal of Medicinal Chemistry. 30. 175s–185s. 1 indexed citations
7.
Azzi, Mounia, Danielle Gully, Michel Héaulme, et al.. (1994). Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonists. European Journal of Pharmacology. 255(1-3). 167–174. 25 indexed citations
8.
Cecchi, R., Tiziano Croci, Robert Boigegrain, et al.. (1994). Synthesis and β-adrenergic activity of atypical β-adrenergic phenylethanolaminotetralin stereoisomers. European Journal of Medicinal Chemistry. 29(4). 259–267. 28 indexed citations
9.
Steinberg, R., Florence Oury-Donat, Jean-Paul Terranova, et al.. (1993). SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome. Psychopharmacology. 112(2-3). 219–227. 8 indexed citations
10.
Maffrand, J.P., D. Gully, Robert Boigegrain, et al.. (1993). Neurotensin receptor agonists and antagonists. Drugs of the Future. 18(12). 1137–1137. 6 indexed citations
11.
Gully, D., Robert Boigegrain, Martine Poncelet, et al.. (1993). Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.. Proceedings of the National Academy of Sciences. 90(1). 65–69. 384 indexed citations
12.
Wermuth, Camille G., et al.. (1992). SR 46559 A and related aminopyridazines are potent muscarinic agonists with no cholinergic syndrome. Bioorganic & Medicinal Chemistry Letters. 2(8). 833–838. 17 indexed citations
13.
Croci, Tiziano, R. Cecchi, Antonio Tarantino, et al.. (1988). Inhibition of rat colon motility by stimulation of atypical beta-adrenoceptors with new gut-specific agents. Pharmacological Research Communications. 20(2). 147–151. 30 indexed citations
14.
FREHEL, D., Robert Boigegrain, & Jean‐Pierre Maffrand. (1984). Syntheses of 2-Alkyl-3-(4-dialkylaminoalkoxy-benzoyl)-thieno[3,2-c]pyridines. Heterocycles. 22(5). 1235–1235. 4 indexed citations
15.
Morre, Michel, André Bachy, Bernard Gout, et al.. (1983). Kappa binding sites in guinea-pig brain membranes: Evidence for a dynorphin-resistant subtype. Life Sciences. 33. 179–182. 18 indexed citations
16.
Morre, Michel, Robert Boigegrain, & R. Roncucci. (1982). Analgesia, new research approaches.. PubMed. 36(6-7). 282–5. 1 indexed citations
17.
Maffrand, Jean‐Pierre, et al.. (1981). Nouvelles voies d'accès à des aryl‐4 thiéno[2,3‐c]pyridines et à des aryl‐7 thiéno[3,2‐c]pyridines. Journal of Heterocyclic Chemistry. 18(4). 727–734. 5 indexed citations
18.
Maffrand, Jean‐Pierre & Robert Boigegrain. (1979). New Synthesis of Thieno[3,2-c]pyridines. Heterocycles. 12(11). 1479–1479. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Batzl‐Hartmann Breakdown of academic impact, for papers by H. YAJIMA Breakdown of academic impact, for papers by D. Gully Breakdown of academic impact, for papers by Kelly P. Longo Breakdown of academic impact, for papers by J.B. Bøler Breakdown of academic impact, for papers by Fredric J. Vinick Breakdown of academic impact, for papers by Bernard Labeeuw Breakdown of academic impact, for papers by J P Moreau Breakdown of academic impact, for papers by Larry S. Birkemo Breakdown of academic impact, for papers by D. Roemer
Rankless by CCL
2026